InsidersTradesSigma
Track the 선바이오 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 선바이오 has recorded 10 public disclosures. Market capitalisation: €78.7bn. The latest transaction was reported on 23 April 2026 (Purchase). Among the most active insiders: 노광. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
10 of 10 declarations
Sunbio opera en el sector de la salud y farmacéutico, cotizada en el mercado XKRX. La empresa se centra en el desarrollo de soluciones innovadoras en el campo de la atención médica.